Proassurance Corporation · NYSE:PRA

Proassurance — 2013 Financials Conference

70 slides from Proassurance's conference presentation, Jun 18, 2013

  1. Slide 1: 2013 Financials Conference

    2013 Financials Conference June 18, 2013 Financials Conference Victor T. Adamo Retiring Vice-Chairman Frank B. O’Neil Investor Relations Officer

  2. Slide 2: Forward Looking Statements and Non-GAAP Measures

    This presentation contains Forward Looking Statements and other information designed to convey our projections and expectations regarding future results. There are a number of factors which could cause our actual results to vary materially from those projected in this presentation. The principal ris

  3. Slide 3: Q1 2013 Highlights

    Q1 2013 Highlights Increased Net and Operating Income Y- O -Y ROE of 13.4% Book Value per share now $38.19 4% increase since year-end 2012 Book Value per Share has grown each year since Shareholder’s Equity and Total Assets at record levels Recent transactions contributing to our results with integr

  4. Slide 4: ProAssurance Corporate Profile

    ProAssurance Corporate Profile Specialty liability insurance writer Healthcare Professional Liability (HCPL) Only “pure play” public company writing predominately HCPL Life sciences and medical devices Attorney’s professional liability Market Cap: ~$3.0 billion Shareholders’ Equity: $2.4 billion Tot

  5. Slide 5: ProAssurance Business Profile

    Distribution Channels HCPL LPL Life Sciences Agent / Broker 64% 75% 100% Direct 36% 25% -- Q1 2013 Policyholders: ~64,600 Q1 2013 Premium: $163.2 mln ProAssurance Business Profile March 31, 2013 Includes Acquisitions Tail Premium Allocated by Line

  6. Slide 6: ProAssurance Geographic Profile

    ProAssurance Footprint / All Lines ProAssurance Geographic Profile Broad geographic diversification Locally-based decision-making differentiates ProAssurance by addressing each state’s unique medical/legal challenges (Birmingham) Corporate Headquarters Corporate Headquarters Claims Offices Claims Of

  7. Slide 7: Seeking Increased Yield But Balancing Risk

    $4.3 Billion Portfolio Fixed Income: 84% Short Term: 2% Equity and Equity Substitutes: 12% BOLI: 1% Seeking Increased Yield But Balancing Risk We continue to focus on maintaining a high quality, well diversified fixed income portfolio We are making incremental changes to obtain higher yields in blue

  8. Slide 8: Management Team

    W. Stancil Starnes, JD Chairman & Chief Executive Officer Company Tenure: 6 Years Prior MPL Experience: 29 Years Total Industry & Related Experience: 35 Years Formerly in the private practice of law in MPL defense and complex corporate litigation Victor T. Adamo, JD, CPCU Retiring as Vice-Chairman o

  9. Slide 9: Our Commitment to Treated Fairly

    Our Commitment to Treated Fairly Unwavering dedication to the defense of non-meritorious lawsuits Allows our insureds the right to an unfettered defense of their claims where permitted by law Steadfast dedication to in-depth underwriting and adequate pricing An unsurpassed level of customer service

  10. Slide 10: Strategies for Future Success

    Strategies for Future Success Our successful experience and deep expertise uniquely qualify ProAssurance to insure the widest range of healthcare risks

  11. Slide 11: Building a Bridge to the Future

    Building a Bridge to the Future Our core business is at a pivot point We are uniquely positioned to succeed by serving the emerging market and remaining legacy business Smaller competitors with less experience and capacity have decisions to make Legacy business is largely single-state, solo and smal

  12. Slide 12: Building a Bridge to the Future

    Building a Bridge to the Future Larger risks will demand sophisticated coverages that span the continuum of healthcare Broad healthcare liability experience is our foundation We added capacity & capability through M&A Example: Medmarc, PICA and Mid-Continent Home Healthcare Non-Traditional Delivery

  13. Slide 13: M & A and the Insurance Cycle

    M & A and the Insurance Cycle ProAssurance’s Successful M&A Strategy Consolidation will continue and will remain episodic Fewer significant targets Remaining companies of size are in important strategic areas We prefer “health care centric” but will consider closely related liability lines Legal/reg

  14. Slide 14: ProAssurance's Successful M&A History

    ProAssurance’s Successful M&A History Original Companies Purchased Company Demutualization OHIC HOSPITALS ONLY Renewal Rights Assumed Business † SERTA

  15. Slide 15: ProAssurance Will Grow Prudently

    ProAssurance Will Grow Prudently ProAssurance is a demonstrated leader in M&A We will broaden our lines of coverage as needed Healthcare-related Through prudent leverage of our expertise and the addition of specialized expertise The market will firm and we are prepared to grow organically Past histo

  16. Slide 16: Strategy for an Evolving Market

    Strategy for an Evolving Market Shaped by a healthcare landscape that will change—with or without federal healthcare reform Expanding our capabilities and commitment across the continuum of healthcare Building on two decades of hospital experience Recent expansion into products liability for life sc

  17. Slide 17: Strategy for an Evolving Market

    Strategy for an Evolving Market Leverage our reach, expertise and financial strength with larger accounts Largest non-profit healthcare system in the US Now in Michigan, Florida, Illinois, Indiana and Texas Insuring Ascension-affiliated physicians through coordinated, jointly insured programs Financ

  18. Slide 18: Strategy for an Evolving Market

    Strategy for an Evolving Market Joint physician/hospital insurance products to address the unique risk tolerance and claims- handling expectation of each insured Partnerships with existing physician-focused companies to leverage hospital expertise Recently announced California venture with CAP-MPT:

  19. Slide 19: Positioned to Succeed

    Positioned to Succeed ProAssurance has the right combination of geographic scope, broad experience, and financial strength for success in the new world of healthcare liability SNL 2012 Statutory Data, MPL Writers with Direct Written Premiums >$80 million

  20. Slide 20: Healthcare Reform

    Healthcare Reform No meaningful change after the election Known: More customers for us May accelerate the growth of hospital-owned practices and consolidation into larger groups Provides an opportunity for us due to our geographic reach, long-term experience in hospitals and our financial strength W

  21. Slide 21: Today's Healthcare Professional Liability Market

    Today’s Healthcare Professional Liability Market ProAssurance delivers an unparalleled level of service and financial stability that truly differentiates our coverage and our Company in an evolving, competitive market

  22. Slide 22: HCPL Stands Apart in Insurance

    HCPL Stands Apart in Insurance HCPL claims may not be filed for years after an incident and may take years to resolve: Long-tail Personal lines are short tail Introduces long periods of uncertainty Loss trends may change expected severity from time of initial pricing Can be mitigated by the use of t

  23. Slide 23: The HCPL Market Today

    The HCPL Market Today Prolonged period of “benign profitability” Premiums levels remain well above levels of 2000 Significant policyholder retention by all companies despite fierce competition No large commercial carriers have entered the market in a meaningful manner Significant barriers to entry i

  24. Slide 24: Market Factors and Cycle Impact

    Factor Frequency Severity Investment Returns Capital Cash Flow Reserves Reinsurance Status Stabilized Some Upward Indications Moderate Low Excess Capacity Becoming Strained Modestly Redundant Sufficient Capacity Cycle Impact Neutral — Harden Neutral Harden Soften Neutral — Harden Soften Neutral

  25. Slide 25: The HCPL Market Today

    The HCPL Market Today Changes in healthcare delivery are changing the underlying dynamics Physicians are combining into larger groups Physician practices are being brought into hospitals through purchase or affiliation Hospitals are combining into large networks requiring greater insurance expertise

  26. Slide 26: The HCPL Market Today

    The HCPL Market Today Market remains fragmented even after two decades of consolidation More than 100 writers Largest market share is ~8% 87% of top 100 companies have <2% 76% of top 100 companies have <1%

  27. Slide 27: ProAssurance's Standing in HCPL

    ProAssurance’s Standing in HCPL ProAssurance is the largest independent publicly-traded writer of HCPL insurance Fourth largest overall writer DPW: SNL Data 2012

  28. Slide 28: Sound Strategy = Consistent Profitability

    Sound Strategy = Consistent Profitability

  29. Slide 29: The Payoff: Consistent Book Value Growth

    Captures our focus on long-term excellence Increased every year we have been public The Payoff: Consistent Book Value Growth Inception to 3/31/13 CAGR: 16% Cumulative: 2,179% 10 Year Summary (2003 -2012) CAGR: 16% Cumulative: 360% Historical Book Value Per Share Split Adjusted Dividends Shown in the

  30. Slide 30: The Payoff: Steady Share Price Increase

    Share price reflects investor confidence in our business decisions and long-term strategy The Payoff: Steady Share Price Increase Historical Share Price Reflects all stock splits 2012 excludes $2.50/share special dividend Inception to 6/15/13 CAGR: 15% Cumulative: 1,874% 10 Year Summary (2003-2012)

  31. Slide 31: Historical Financial Performance

    Net Income 1 Operating Income 2 Historical Financial Performance Our disciplined, long-term approach drives consistent profitability $ in millions 1 Includes a gain of $35.5 million in the first quarter of 2013 in connection with our acquisition of Medmarc as a result of the value of the net assets

  32. Slide 32: Q1 2013 Income Statement Highlights

    March 31, Y-OVER-Y Change 2013 2012 Gross Premiums Written $ 163 $ 170 -4% Net Investment Result 32 31 +2% Total Expenses (Includes Loss Costs) 95 105 -10% Net Income (Includes Realized Investment Gains & Losses and gain on acquisition) $ 113 $ 56 +103% Operating Income $ 60 $ 48 +24% Net Income per

  33. Slide 33: 2012 Income Statement Highlights

    December 31, Y-OVER-Y Change 2012 2011 Gross Premiums Written $ 536 $ 566 -5% Net Investment Result 129 132 -2% Total Expenses (Includes Loss Costs) 320 302 +6% Net Income (Includes Realized Investment Gains & Losses) $ 275 $ 287 -4% Operating Income $ 257 $ 279 -8% Net Income per Diluted Share $4.4

  34. Slide 34: Consistent Approach to Reserves

    Consistent Approach to Reserves Consistent reserving practices provide protection against a loss trend reversal and capital erosion $ in thousands

  35. Slide 35: Five Year Premium History

    Five Year Premium History Disciplined Underwriting Consistently writing profitable business to ensure long-term success Premium decline driven by competition, physician consolidation and rate actions driven by an unprecedented favorable loss environment Gross Premiums Written Net Premiums Earned

  36. Slide 36: Q1 2013 Balance Sheet Highlights

    Shareholders’ Equity Q1 2013 Balance Sheet Highlights Split adjusted, in billions, except Book Value per share Shareholders’ Equity $ 2.4 $ 2.3 +4% Total Investments 4.3 3.9 +10% Total Assets 5.2 4.9 +6% Policy Liabilities 2.5 2.3 +9% 3/31/13 12/31/12 CHANGE 66% increase since 2008 Book Value per Sh

  37. Slide 37: Long-Term Financial Strength

    Total Assets Long-Term Financial Strength Our balance sheet is our top financial priority Financial strength differentiates us in the market The claims defense philosophy that differentiates us in the market leverages our financial strength

  38. Slide 38: Returning Capital to Shareholders

    Returning Capital to Shareholders Capital Management Priorities Preferred use is to support growth through M&A or new business We balance future needs with current market reality Regular dividend is $1.00/share ~2% yield based on current share price Prudent share repurchase program $321 million spen

  39. Slide 39: ProAssurance vs. Industry Loss Ratios

    Source: 1991-2011 A.M. Best Aggregates and Averages, Medical Malpractice Lines of Business 2012: Preliminary A. M. Best industry data from special report issued 5/6/13 Five Years: ProAssurance Average: 58.7% / Industry Average: 84.4% Ten Years: ProAssurance Average: 77.8% / Industry Average: 94.7% 1

  40. Slide 40: ProAssurance Outperforms the Industry

    ProAssurance Outperforms the Industry 2004-2011 A.M. Best Aggregates and Averages, Medical Malpractice Lines of Business 2012: Preliminary SNL Data Weighted Average High/Low Industry Average ProAssurance

  41. Slide 41: ProAssurance Pricing History

    MD/DO Rate Change History ProAssurance Pricing History Peak pricing was in 2006 Improved frequency trends are reflected in recent rate declines Improvement in frequency has outweighed the steady, manageable rise in severity Loss trends have improved in states with and without tort reforms Rate chang

  42. Slide 42: ProAssurance Retention Remains High

    ProAssurance Retention Remains High Continued underwriting vigilance is being used today to ensure future success Market share is important, but NOT as important as profitability Retention remains in line with recent quarters

  43. Slide 43: ProAssurance Operational Review

    ProAssurance Operational Review ProAssurance delivers an unparalleled level of service and financial stability that truly differentiates our coverage and our Company in an evolving, competitive market

  44. Slide 44: Underwriting for Profitability Not Market Share

    Underwriting for Profitability Not Market Share Underwriting process driven by individual risk selection and assessment of loss history, areas of practice, and location Rates contemplate specific ROE expectations Frequent rate/loss reviews ensure adequate prices Rate filings consider the results of

  45. Slide 45: Key State Rate Comparison

    Key State Rate Comparison Annual Premium for a $1M / $3M Policy Filed or Approved at 1/01/13

  46. Slide 46: Understanding Recent Loss Trends

    Understanding Recent Loss Trends Frequency stable after historic declines Lawyers are the gatekeepers Must weigh the cost of a trial vs. chances of success Likelihood of success is affected by many factors Societal perceptions of lawsuits against physicians Effects of the overall Tort Reform debate

  47. Slide 47: Claims Trends Remain Favorable

    New Claims Opened Each Year ProAssurance Claims Tried to a Verdict Claims Trends Remain Favorable Fewer cases to try following significant decline in frequency Severity trends steady and manageable No observed effect from the economic downturn Trends are much the same in states with or without Tort

  48. Slide 48: Differentiate Through Claims Defense

    ProAssurance: 78% No Paid Losses Industry: 72% No Paid Losses Differentiate Through Claims Defense We leverage our financial strength to give our insureds the opportunity for an uncompromising defense of each claim Differentiates our product Provides long-term financial and marketing advantages Reta

  49. Slide 49: The Ohio Example: 2005-2011 Data

    More Claims Closed With No Indemnity More Claims Defended in Court Lower Average Indemnity Payment per Closed Claim The Ohio Example: 2005 - 2011 Data Comprehensive, reliable data provided by the Ohio Department of Insurance Broad range of competitors and business approaches www.insurance.ohio.gov/L

  50. Slide 50: The Bottom Line Benefits of Strong Defense

    Loss Payments as a Percentage of Total Loss Ratio 19% 21% 32% 48% 42% 44% The Bottom Line Benefits of Strong Defense Our ability and willingness to defend claims allows us to achieve better results Source: Statutory Basis, A.M. Best Aggregates & Averages Some totals may not agree due to rounding Pro

  51. Slide 51: ProAssurance: Treated Fairly

    PROASSURANCE. “Treated Faily

  52. Slide 52: Capital Growth: 2008-Q1 2013

    Capital Growth: 2008-Q1 2013 in $000’s except total equity (000,000’s) * Includes economic cost of holding treasury shares

  53. Slide 53: Inside ProAssurance's Balance Sheet

    Inside ProAssurance’s Balance Sheet 3/31/13

  54. Slide 54: Inside ProAssurance's Income Statement

    Inside ProAssurance’s Income Statement 3/31/13 $35.5 Non-Taxable Gain on Acquisition

  55. Slide 55: Recent Book Value per Share History

    Recent Book Value per Share History

  56. Slide 56: Steady Return in an Unfavorable Environment

    Steady Return in an Unfavorable Environment Long-term ROE target: 12% -14%

  57. Slide 57: Current Prices Reflect the Solid Value of ProAssurance

    Current Prices Reflect the Solid Value of ProAssurance Current Price to Q1 2013 Book: 1.4x Average Since Inception: 1.4x Driven to Excel / Focused on Shareholder Value Maintaining profitability Continuing growth in book value per share Producing sustainable shareholder value Focusing on long-term—re

  58. Slide 58: ProAssurance Transaction Discussion

    ProAssurance Transaction Discussion Medmarc is broadening our product offerings and capabilities in protecting the delivery of healthcare With the acquisition of Independent Nevada Doctors Insurance Exchange (IND), ProAssurance becomes the leading medical professional liability writer in Nevada

  59. Slide 59: Medmarc Transaction Update

    Medmarc Transaction Update A leading products liability writer in medical technology and life sciences Meaningful legal professional liability book Acquisition completed effective January 1, 2013 Functioning as an operationally independent subsidiary Broad acceptance in Medmarc’s target markets Coor

  60. Slide 60: IND Transaction Update

    IND Transaction Update Leading MPL writer in Nevada Acquisition completed in late November 2012 Integration well underway and proceeding smoothly New business opportunities evolving as agents understand the scope and capability of the combined organizations

  61. Slide 61: Investment Portfolio Detail

    Investment Portfolio Detail ProAssurance remains conservatively invested, to ensure our ability to keep our long-term promise of insurance protection

  62. Slide 62: ProAssurance: Investment Profile

    $4.3 Billion Overall Portfolio $3.6 Billion Fixed Income Portfolio ProAssurance: Investment Profile Average duration: 3.9 years Average tax-equivalent income yield: Q1 13: 4.2% / Q1 12: 4.4% Investment grade: 93% Weighted average: A+ 03/31/13 Tax credit portfolio not reflected in investment income—p

  63. Slide 63: Portfolio Detail: Asset Backed

    Asset Backed: $490 Million ProAssurance Portfolio Detail: Asset Backed 03/31/13 Subject to Rounding Weighted Average Rating: “AA+”

  64. Slide 64: Portfolio Detail: Corporate

    Corporates: $1.6 Billion ProAssurance Portfolio Detail: Corporate Weighted Average Rating: A- 3/31/13

  65. Slide 65: Portfolio Detail: Municipals

    Municipals: $1.3 Billion / Average Rating is AA ProAssurance Portfolio Detail: Municipals Investment policy has always required investment grade rating prior to applying the effect of insurance Weighted Average Rating: AA 12/31/12

  66. Slide 66: Portfolio Detail: Equities & Other

    Equities & Other: $489 Million ProAssurance Portfolio Detail: Equities & Other 12/31/12 4.9% TE Book Yield 13% TE IRR

  67. Slide 67: Portfolio Detail: Various

    Treasury / GSE: $291 Million Short Term: $149 Million BOLI: $53 Million ProAssurance Portfolio Detail: Various Rated A1/P1 or better Money Markets: Moody’s: Aaa S&P: AAA Weighted average rating Moody’s: AA3 S&P: AA- A. M. Best: A+ 03/3/13

  68. Slide 68: ProAssurance: Treated Fairly

    PROASSURANCE. “Treated Faily

  69. Slide 69: Debt to Equity Strong Capital Position

    Debt to Equity Strong Capital Position Prepared for an improving market Conservative Use of Debt / Low Leverage Credit facility accessed for $125 million in short-term borrowing (December 2012) No Debt Prior to 2001

  70. Slide 70: Long-Term ROE Target and The Yield Trap

    Long-Term ROE Target is 12%-14% The Yield Trap The choice: chase yield or extend duration We are maintaining duration, looking for opportunities Pricing discipline becomes even more critical in a low interest rate environment Lack of investment yield may be a hard market catalyst Return on Equity an

ProAssurance — 2013 Financials Conference on 6ix